Results from a new trial found that an “extremely potent” antibody can dramatically reduce the level of the HIV virus in a patient’s blood — raising hopes for an HIV vaccine. Researchers at Rockefeller...
The Bill & Melinda Gates Foundation and CureVac announced that the foundation has made a commitment to invest $52 million in CureVac, a leading clinical-stage biopharmaceutical company specializing in mRNA-based...
A decade on from the Northern Nigeria polio vaccination boycott and its global costs to the polio eradication initiative, a new report examines global issues affecting vaccine confidence and hesitation since the new...
A vaccine licensed in China protected healthy adults against hepatitis E virus infection for up to 4.5 years, according to newly published data. “Vaccine development has been facilitated by the observation that all...
Two experimental Ebola vaccinations “appear to be safe” after testing in Liberia. Meanwhile, a British nurse has been cleared of the virus, but doctors cautioned speculation about the drug’s role in her recovery. The...
Scientists have devised a more effective way to fight tuberculosis by identifying proteins in Mycobacterium tuberculosis (Mtb), the bacterium that causes the disease. Pharma companies can now concentrate on making drugs...
A major problem with current testing for infectious diseases in Africa is that it focuses on individual diseases and cannot reliably discriminate between them. Since most infectious diseases have the same feverish...
Putting an end to a lethal virus may mean going directly to the source, as one study suggests a possible approach to stopping the transmission of the Ebola virus. Michael Jarvis, PhD, and his Plymouth University...
Researchers have identified a powerful antibody which requires a minute amount to neutralise the dengue virus, paving the way for effective treatment of the mosquito-borne infection. A new study showed how a newly...
Protection against leading cause of acute hepatitis lasted more than 4 years, Chinese researchers report. A vaccine against hepatitis E (HEV) provided protection against the virus for more than 4 years, researchers...